ES2137015T3 - Compuesto, eventualmente bajo la forma de un isomero puro o de una mezla de estos isomeros. - Google Patents
Compuesto, eventualmente bajo la forma de un isomero puro o de una mezla de estos isomeros.Info
- Publication number
- ES2137015T3 ES2137015T3 ES96930216T ES96930216T ES2137015T3 ES 2137015 T3 ES2137015 T3 ES 2137015T3 ES 96930216 T ES96930216 T ES 96930216T ES 96930216 T ES96930216 T ES 96930216T ES 2137015 T3 ES2137015 T3 ES 2137015T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- isomers
- eventually
- mixture
- pure isomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPUESTOS QUE RESPONDEN A LA FORMULA GENERAL (I), EN LA CUAL AR REPRESENTA: (A) UN GRUPO FENILO SUSTITUIDO POR UN ATOMO DE HALOGENO; O BIEN (B) UN GRUPO DE FORMULA GENERAL (I ) EN LA CUAL X REPRESENTA UN GRUPO DE FORMULA - CH 2 -, (CH 2 ) 2 - O - (CH 2 ) 3 - Y Z REPRESENTA UN ATOMO DE HIDROGENO O DE HALOGENO O UN GRUPO METILO; Y REPRESENTA UN GRUPO DE FORMULA - CH 2 -, - CO - O - CHOH - ; R 1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METILO; R 2 RE PRESENTA UN GRUPO CICLOALQUILO EN C 3 - C 7 ; Y N REPRESENTA EL NUMERO 0, 1, 2 O 3. APLICACION TERAPEUTICA COMO AGENTES NEUROTROFICOS Y NEUROPROTECTORES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9510513A FR2738566B1 (fr) | 1995-09-08 | 1995-09-08 | Derives de 4-(cycloalkyl)piperidines et de 4-(cycloalkylalkyl)piperidines, leur preparation et leur application en therapeutique |
FR9510512A FR2738568B1 (fr) | 1995-09-08 | 1995-09-08 | Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2137015T3 true ES2137015T3 (es) | 1999-12-01 |
Family
ID=26232195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96930216T Expired - Lifetime ES2137015T3 (es) | 1995-09-08 | 1996-09-05 | Compuesto, eventualmente bajo la forma de un isomero puro o de una mezla de estos isomeros. |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0848707B1 (es) |
JP (1) | JPH11514975A (es) |
KR (1) | KR19990044479A (es) |
CN (1) | CN1201453A (es) |
AR (1) | AR003530A1 (es) |
AT (1) | ATE182885T1 (es) |
AU (1) | AU703776B2 (es) |
BG (1) | BG102282A (es) |
BR (1) | BR9610408A (es) |
CA (1) | CA2231326A1 (es) |
CO (1) | CO4750660A1 (es) |
CZ (1) | CZ66598A3 (es) |
DE (1) | DE69603613T2 (es) |
EE (1) | EE9800064A (es) |
ES (1) | ES2137015T3 (es) |
GR (1) | GR3031513T3 (es) |
HU (1) | HUP9802938A2 (es) |
IL (1) | IL123557A0 (es) |
NO (1) | NO981000L (es) |
NZ (1) | NZ316981A (es) |
PL (1) | PL325421A1 (es) |
SI (1) | SI0848707T1 (es) |
SK (1) | SK31198A3 (es) |
TR (1) | TR199800407T1 (es) |
WO (1) | WO1997009309A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2295098A1 (en) | 1997-06-30 | 1999-01-07 | Allergan Sales, Inc. | Calcium blockers to treat proliferative vitreoretinopathy |
KR20020002356A (ko) | 1998-10-27 | 2002-01-09 | 제임스 에이. 아노 | 외부 망막 손상의 치료 |
JP2008501343A (ja) * | 2004-06-04 | 2008-01-24 | ワシントン・ユニバーシティ | 神経障害を治療するための方法および組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4028366A (en) * | 1975-01-20 | 1977-06-07 | Sterling Drug Inc. | 2-Naphthyl-lower-alkanoylamines |
FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
FR2684379B1 (fr) * | 1991-12-02 | 1995-04-28 | Synthelabo | Derives de piperidine, leur preparation et leur application en therapeutique. |
WO1994018172A1 (en) * | 1993-02-01 | 1994-08-18 | Yoshitomi Pharmaceutical Industries, Ltd. | Imidazolylbenzene compound and use thereof as medicine |
-
1996
- 1996-09-05 IL IL12355796A patent/IL123557A0/xx unknown
- 1996-09-05 TR TR1998/00407T patent/TR199800407T1/xx unknown
- 1996-09-05 AU AU69344/96A patent/AU703776B2/en not_active Ceased
- 1996-09-05 DE DE69603613T patent/DE69603613T2/de not_active Expired - Fee Related
- 1996-09-05 EE EE9800064A patent/EE9800064A/xx unknown
- 1996-09-05 HU HU9802938A patent/HUP9802938A2/hu unknown
- 1996-09-05 CO CO96047348A patent/CO4750660A1/es unknown
- 1996-09-05 BR BR9610408A patent/BR9610408A/pt not_active Application Discontinuation
- 1996-09-05 WO PCT/FR1996/001362 patent/WO1997009309A1/fr not_active Application Discontinuation
- 1996-09-05 JP JP9510910A patent/JPH11514975A/ja active Pending
- 1996-09-05 PL PL96325421A patent/PL325421A1/xx unknown
- 1996-09-05 KR KR1019980701727A patent/KR19990044479A/ko not_active Application Discontinuation
- 1996-09-05 CN CN96198170A patent/CN1201453A/zh active Pending
- 1996-09-05 CZ CZ98665A patent/CZ66598A3/cs unknown
- 1996-09-05 SI SI9630106T patent/SI0848707T1/xx unknown
- 1996-09-05 EP EP96930216A patent/EP0848707B1/fr not_active Expired - Lifetime
- 1996-09-05 AT AT96930216T patent/ATE182885T1/de active
- 1996-09-05 SK SK311-98A patent/SK31198A3/sk unknown
- 1996-09-05 CA CA002231326A patent/CA2231326A1/en not_active Abandoned
- 1996-09-05 ES ES96930216T patent/ES2137015T3/es not_active Expired - Lifetime
- 1996-09-05 NZ NZ316981A patent/NZ316981A/xx unknown
- 1996-09-06 AR ARP960104270A patent/AR003530A1/es unknown
-
1998
- 1998-02-26 BG BG102282A patent/BG102282A/xx unknown
- 1998-03-06 NO NO981000A patent/NO981000L/no unknown
-
1999
- 1999-10-13 GR GR990402608T patent/GR3031513T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
BR9610408A (pt) | 1999-07-06 |
CO4750660A1 (es) | 1999-03-31 |
AU6934496A (en) | 1997-03-27 |
SI0848707T1 (en) | 2000-02-29 |
JPH11514975A (ja) | 1999-12-21 |
EP0848707A1 (fr) | 1998-06-24 |
AR003530A1 (es) | 1998-08-05 |
AU703776B2 (en) | 1999-04-01 |
CZ66598A3 (cs) | 1998-06-17 |
DE69603613D1 (de) | 1999-09-09 |
MX9801838A (es) | 1998-08-30 |
BG102282A (en) | 1998-09-30 |
WO1997009309A1 (fr) | 1997-03-13 |
PL325421A1 (en) | 1998-07-20 |
HUP9802938A2 (hu) | 1999-10-28 |
KR19990044479A (ko) | 1999-06-25 |
NO981000L (no) | 1998-05-08 |
EP0848707B1 (fr) | 1999-08-04 |
SK31198A3 (en) | 1998-08-05 |
DE69603613T2 (de) | 2000-03-02 |
EE9800064A (et) | 1998-08-17 |
IL123557A0 (en) | 1998-10-30 |
CN1201453A (zh) | 1998-12-09 |
TR199800407T1 (xx) | 1998-05-21 |
NO981000D0 (no) | 1998-03-06 |
CA2231326A1 (en) | 1997-03-13 |
ATE182885T1 (de) | 1999-08-15 |
NZ316981A (en) | 1998-12-23 |
GR3031513T3 (en) | 2000-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2179273T3 (es) | N-bencil-2-fenilindolas como agentes estrogenicos. | |
ES2037723T3 (es) | Amidinacion selectiva de diaminas. | |
ATE82499T1 (de) | Okulare hypotensivagenzien. | |
FI925615A0 (fi) | Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening | |
BG102259A (en) | Compostions with controlled paroxetine release | |
MX9301643A (es) | Composiciones de fragancia, no terapeuticas que contienen feromonas de humano. | |
GT199900067A (es) | Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica. | |
ES2184070T3 (es) | Derivados de oximas sustituidas utiles como antagonistas de la neuroquinina. | |
ES2071020T3 (es) | Derivados de n-fenilpirazol. | |
AR000929A1 (es) | Compuestos herbicidas de bencisoxazol y bencisotiazol substituido, composicion que los comprende y metodos para controlar con los mismos especiesde plantas indeseables. | |
DK0767798T3 (da) | Sterolderivater anvendt til regulering af meiose | |
ATE13667T1 (de) | 8-aza-16,16-difluor-prostanoide. | |
DE3580132D1 (de) | Aromatische verbindungen. | |
DK339386D0 (da) | Aromatiske forbindelser | |
ES2137015T3 (es) | Compuesto, eventualmente bajo la forma de un isomero puro o de una mezla de estos isomeros. | |
ES2066546T3 (es) | Composicion farmaceutica para inhibir la resorcion osea. | |
DK578887D0 (da) | Antihypertensiva | |
ES2097423T3 (es) | Analogos de vitamina d3. | |
NO20001758L (no) | FremgangsmÕter og blandinger for behandling av leddgikt | |
ES2099865T3 (es) | Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares. | |
NO943765L (no) | Aryloksybenzen-herbicidmidler | |
MX9300008A (es) | Nucleosidos terapeuticos. | |
ATE139519T1 (de) | Stabilisiertes 141b | |
AR001561A1 (es) | Procedimiento para la obtención de cis isómeros sustancialmente puros a partir de una mezcla de isómeros cis y trans de o-bisoximas | |
SE8602060D0 (sv) | Farmaceutiska kompositioner som innehaller reducerad glutation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 848707 Country of ref document: ES |